Istari Oncology

About:

Istari Oncology is a biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma.

Website: http://www.istarioncology.com/

Description:

Istari Oncology is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. The Company was founded in 2016 by Darell Bigner, MD, and Matthias Gromeier, MD to continue research and clinical development of technology discovered at Duke University.

Total Funding Amount:

$48.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)istarioncology.com

Founders:

Dani P. Bolognesi, Matthias Gromeier

Number of Employees:

11-50

Last Funding Date:

2021-04-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai